India city Pune hospital India city Pune

₹140 cr in 2 firms

Reading now: 808
www.livemint.com

₹70 crore each in ophthalmology hospital chain Sharp Sight and Pune-based Murli Krishna Pharma Pvt. Ltd, a formulations maker that focuses on developing novel drug delivery system (NDDS) products Healthcare services and pharma focused private equity (PE) fund, India Life Sciences Fund III, made two investments worth ₹140 crore in the lockdown period.The PE firm invested ₹70 crore each in ophthalmology hospital chain Sharp Sight and Pune-based Murli Krishna Pharma Pvt.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA